Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07120347 · ClinicalTrials.gov registry record · NA
Remote Sensing for ADRD-Specific Activities Identification in Older Adults
A NA study of Mild Cognitive Impairment (MCI) and Alzheimer Disease and Related Dementias (ADRD), sponsored by University of Missouri-Columbia.
- Recruiting
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT07120347: Recruiting NA study of Mild Cognitive Impairment (MCI) and Alzheimer Disease and Related Dementias (ADRD), sponsored by University of Missouri-Columbia.
NCT07120347 is a NA study of Mild Cognitive Impairment (MCI) and Alzheimer Disease and Related Dementias (ADRD) that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 16 participants, below the 159-participant average among 19 other Mild Cognitive Impairment (MCI) trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07120347, a NA study of Mild Cognitive Impairment (MCI) and Alzheimer Disease and Related Dementias (ADRD), is actively recruiting participants, sponsored by University of Missouri-Columbia.
- RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators aim to use smart-home sensors and artificial intelligence (AI) to monitor and detect Alzheimer's Disease and Related Dementias (ADRD)-specific daily activities among older adults, with the goal of early symptom detection and personalized support. Dementia, which impacts memory and cognition, remains a global concern. In the United States, more than 6.7 million individuals aged 65 and older are living with ADRD, and projected annual healthcare costs are expected to reach $1 trillion by 2050. This underscores the need for deeper understanding and innovative support. To address the unique challenges associated with ADRD, such as cognitive decline, personalized strategies that promote independent well-being are essential. Smart-home sensors can support older adults with ADRD as they continue to live in their homes. These sensors provide real-time data on health and daily activities, offering insights into their daily lives. However, adoption of these technologies is low, and the practical application of AI remains limited. This highlights the need for further research to make these devices more accessible to this population. The investigators' aims include: Conducting focus groups with individuals with and without ADRD and their caregivers to identify daily activities that can be measured using in-home sensors; Collecting in-home sensor data from older adults with and without ADRD; and Using AI to develop a tool for recognizing daily activities. The integration of smart-home sensors with advanced data-analysis techniques holds significant potential for transforming the support and care provided to individuals with ADRD. Ultimately, the investigators' findings will contribute to improving the quality of life for affected individuals and alleviating the burden on caregivers and healthcare systems.
Primary Outcome
Percent of daily activity labels correctly predicted by SVM, XGBoost, LSTM and Transformer models, trained and tested on ambient motion and environmental sensor data collected during weeks 1-4 from participants with and without early-stage ADRD.
Conditions Studied
Interventions
- OTHER Remote Ambient Sensor System
Study Locations (1)
Missouri
- University of Missouri - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
What NCT07120347 shows while recruiting
NCT07120347 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 159-participant average among 19 other Mild Cognitive Impairment (MCI) trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Mild Cognitive Impairment (MCI) appearing as the primary indexed condition, and to 1 intervention - of which Remote Ambient Sensor System is the first listed.
NCT07120347 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT07120347 about?
NCT07120347 is a clinical study titled "Remote Sensing for ADRD-Specific Activities Identification in Older Adults". The investigators aim to use smart-home sensors and artificial intelligence (AI) to monitor and detect Alzheimer's Disease and Related Dementias (ADRD)-specific daily activities among older adults, with the goal of early symptom detection and personalized support. Dementia, which impacts memory and ...
What is the current status of trial NCT07120347?
This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2024-08-01. Estimated completion is 2027-07-31.
What conditions does trial NCT07120347 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment (MCI), Alzheimer Disease and Related Dementias (ADRD).
What interventions are being tested in trial NCT07120347?
The interventions under investigation include: Remote Ambient Sensor System (OTHER).
Who is sponsoring clinical trial NCT07120347?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07120347 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment (MCI)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07120347's enrollment target sits among peer trials
16 16th of 19 higher than 3 of 19 other Mild Cognitive Impairment (MCI) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Cognitive Impairment (MCI) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Music for the Mind Study
RECRUITING · NA
-
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
RECRUITING · NA
-
The "Let's Talk Tech" Tool to Support Decision Making About Technology Use
RECRUITING · NA
-
Project Gnosis: the Neurophysical and Psychosocial Health Outcomes of Tai Chi for Older Adults with Cognitive Concerns or Mild Cognitive Impairment
RECRUITING · NA
-
Working Memory Training in Patients with Mild Cognitive Impairment
RECRUITING · NA
-
Treating Insomnia in Mild Cognitive Impairment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI